IHT Wealth Management’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2
Closed -$19.2K 1036
2023
Q4
$19.2K Hold
2
﹤0.01% 971
2023
Q3
$32.5K Hold
2
﹤0.01% 950
2023
Q2
$78.1K Hold
2
﹤0.01% 938
2023
Q1
$75K Buy
2
+1
+100% +$56.4K ﹤0.01% 914
2022
Q4
$75.9K Hold
1
﹤0.01% 875
2022
Q3
$74K Hold
1
0.01% 835
2022
Q2
$73K Hold
1
0.01% 709
2022
Q1
$118K Hold
1
0.01% 736
2021
Q4
$69K Hold
1
0.01% 783
2021
Q3
$140K Hold
1
0.01% 765
2021
Q2
$108K Hold
1
0.01% 905
2021
Q1
$140K Hold
1
0.01% 797
2020
Q4
$122K Hold
1
0.01% 714
2020
Q3
$139K Hold
1
0.01% 617
2020
Q2
$130K Hold
1
0.02% 547
2020
Q1
$100K Buy
+1
New +$103K 0.01% 509
2019
Q4
Hold
0
-$16K 636
2019
Q3
Hold
0
607
2019
Q2
Hold
0
539

Other funds holding GNPX

IHT Wealth Management's GNPX Position: Q1 2024 in Review

IHT Wealth Management sold out of Genprex (GNPX) in Q1 2024, closing a stake of 2 shares — an estimated $19.2K sold.

IHT Wealth Management first reported a position in GNPX in Q1 2020 and held it in 16 quarters. The position peaked at $140K in Q3 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • IHT Wealth Management reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • IHT Wealth Management sold 2 Genprex shares in Q1 2024, an estimated $19.2K.
  • IHT Wealth Management first reported a position in Genprex in Q1 2020 and held it in 16 quarters.
  • IHT Wealth Management's Genprex position peaked at $140K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on IHT Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.